Clinical trial · Observational
Uterine Artery Embolization for Symptomatic Fibroids
Short and Long Term Outcomes of Uterine Artery Embolization.
NCT00354471CI-TRIAL-00001978completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will evaluate the safety, efficacy , quality of life and patient satisfaction of uterine artery embolization for the treatment of symptomatic uterine fibroids. It will provide useful information in the development od guidelines in patient selection, procedural management and subsequent follow up.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenomyosis | — | UNRESOLVED | — |
| Menorrhagia | — | UNRESOLVED | — |
| Uterine Fibroids | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Uterine Artery Embolization | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Symptoms related to the pressence of uterine fibroids serious enough to consider surgical options * Confirmation of fibroids by endovaginal and transabdominal ultrasound Exclusion Criteria: * Pedunculated fibroids * Desire for fertility * Carcinoma of pelvic organs * Previous pelvic irradiation * Bleeding diathesis and vasculitis * History of allergiy to contrst medium
References
Publications (0)
Data not yet available
No reference posted for this study.